Paradigm Biopharmaceuticals | PAR - Operating Profit

Stock Price
0.27
Daily Change
-0.01 -1.82%
Monthly
-15.63%
Yearly
-50.00%
Q1 Forecast
0.27

Paradigm Biopharmaceuticals reported AUD-8.5M in Operating Profit for its fiscal semester ending in June of 2025.





Operating Profit Change Date
Avita Medical AUD -11.15M 1.19M Jun/2025
Medical Developments International AUD -480K 662K Jun/2025
Neuren Pharmaceuticals AUD 5.45M 171.24M Jun/2025
Pacific Edge NZD -19.4M 2.91M Dec/2025
PYC Therapeutics AUD -13.47M 12.42M Jun/2025
Telix Pharmaceuticals AUD 8.04M 3.21M Dec/2025